Active Ingredient(S)
Loratadine 10mg
The following Structured Product Label (SPL) was submitted to the FDA by Marksans Pharma Limited for the product Loratadine (NDC 25000-021). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, use(s), warnings, ask a doctor before use if, when using this product, stop use and ask doctor if, pregnancy/breastfeeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loratadine 10mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies
• runny nose
• sneezing
• itchy, water eyes
• itching of the nose or throat
Do not use if you have ever had an allergic reaction to this product or any of its ingredients
you have liver or kidney disease. Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
an allergic reaction to this product occurs. Seek medical help right away
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 6 years and over: 1 capsule daily; Not more than 1 capsule in 24 hours.
Children under 6 years of age: ask a doctor.
Consumers with Liver or kidney disease: ask a doctor.
FD&C Blue no. 1, gelatine, mono anddiglyceride of caprilic/capric acid, pharmaceutical ink, polysorbate 80,povidone, purified water, sorbitol, sorbitan solution.
Store at 20°-25°C (68°-77°F).
Protect from freezing.
Safely sealed: do not use if the safety seal is open or torn.
NDC# 25000-021-13
Loratadine Capsules, 10 mg
600 counts Bottle Label
NDC# 25000-021-34
Loratadine Capsules, 10 mg
28 counts Blister Pack
* Please review the disclaimer below.